Population/Individual Bioequivalence [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2015-02-02 14:30 (3364 d 11:57 ago) – Posting: # 14352
Views: 8,284

Hi Kaushik,

❝ I have read in a BEBAC forum posted by HS that the concept of Individual/Population Bioequivalence is no longer considered by FDA/other regulatory agencies, Is it true?


AFAIK, yes.

❝ Finally, I would like to hear […] about the status of IBE/PBE statistical analysis, Does it have any relevance now?


No. If the FDA is concerned, parts of the methodology enter the scene through the back door, e.g., com­paring within-subject variances of NTIDs (warfarin guidance) and the subject-by-formulation inter­action (ER methylphenidate guidance).

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,988 posts in 4,825 threads, 1,656 registered users;
91 visitors (0 registered, 91 guests [including 4 identified bots]).
Forum time: 03:27 CEST (Europe/Vienna)

The whole purpose of education is
to turn mirrors into windows.    Sydney J. Harris

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5